Text Registration
Copyright Title
Hodgkin's disease treatment following M O P P therapy failure
Status
Published
on 14 Jun 2007
Year of Creation
1982
Copyright Claimant
Bristol Laboratories, division of Bristol-Myers Company
Registration Number
TX0001014289
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0001014289) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Hodgkin's disease treatment following M O P P therapy failure" created in 1982. The copyright holder is Bristol Laboratories, division of Bristol-Myers Company, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Bristol Laboratories, division of Bristol-Myers Company.
Application Details
Registration Number
TX0001014289
Registration Date
6/14/2007
Year of Creation
1982
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Bristol-Myers Company. Bristol Laboratories
Physical Description
35 p
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.